276
Views
42
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition

, , , , &
Pages 20-24 | Received 09 Mar 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kasper Broedbaek & Linda Hilsted. (2016) Chromogranin a as Biomarker in Diabetes. Biomarkers in Medicine 10:11, pages 1181-1189.
Read now
Jens P Goetze, Urban Alehagen, Allan Flyvbjerg & Jens F Rehfeld. (2014) Chromogranin a as a Biomarker in Cardiovascular Disease. Biomarkers in Medicine 8:1, pages 133-140.
Read now
Karin E. Bakkelund, Helge L. Waldum, Ivar Skjåk Nordrum, Øyvind Hauso & Reidar Fossmark. (2010) Long-term gastric changes in achlorhydric H+/K+-ATPase beta subunit deficient mice. Scandinavian Journal of Gastroenterology 45:9, pages 1042-1047.
Read now

Articles from other publishers (39)

Alexandra W. Acher & Julie Hallet. (2024) Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors. Surgical Clinics of North America.
Crossref
Julie Hallet & Callisia N. Clarke. (2024) ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. Annals of Surgical Oncology 31:3, pages 1704-1713.
Crossref
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer & Julian M. M. Rogasch. (2023) Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers 15:24, pages 5717.
Crossref
Maha J Alkhayat, Kaamela Davis, Sarah J Atkins, Asad A Sheikh & Muhammad W Saif. (2023) Ten-Fold Elevation of Chromogranin A Level Unrelated to a Neuroendocrine Tumor: A Case Report of the Diagnostic Interference of Proton Pump Inhibitors. Cureus.
Crossref
Sarath S. Joseph, Dan H. V. Tran, Farhadul Islam & Vinod Gopalan. 2023. Current Cancer Biomarkers. Current Cancer Biomarkers 148 179 .
重杰 李. (2023) Research Progress on Risk Factors Related to Gastric Fundus Glandular Polyps. Advances in Clinical Medicine 13:12, pages 20008-20012.
Crossref
Helge Waldum & Reidar Fossmark. (2021) Gastritis, Gastric Polyps and Gastric Cancer. International Journal of Molecular Sciences 22:12, pages 6548.
Crossref
Ilja Tacheci, Rudolf Repak, Miroslav Podhola, Lucie Benesova, Jiri Cyrany, Jan Bures & Darina Kohoutova. (2021) Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) – A Helicobacter-opposite point. Best Practice & Research Clinical Gastroenterology 50-51, pages 101728.
Crossref
Mohammadali Khorasani, Calvin H. L. Law, Sten Myrehaug, Simron Singh, Angela Assal, Eugene Hsieh, Moises Cukier & Julie Hallet. 2020. Surgical Oncology Manual. Surgical Oncology Manual 345 381 .
. (2019) Re: Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer. The Prostate. 2019;1–7. The Prostate 79:7, pages 813-814.
Crossref
Rossella Rotondo, Flavio Rizzolio, Tiziana Perin, Massimiliano Berretta, Fabrizio Zanconati, Antonio Giordano & Vincenzo Canzonieri. 2019. Gastric Cancer In The Precision Medicine Era. Gastric Cancer In The Precision Medicine Era 53 82 .
Helen L. Robbins, Megan Symington, Barbara Mosterman, Fiona Tranter, Louise Davies, Harpal S. Randeva, Ana Penedo, Clara Ferreira, Catherine Darby, Dimitri Grammatopoulos, Gregory Kaltsas & Martin O. Weickert. (2019) Effects of intake of breakfast or caffeine-containing beverages on measurement of circulating chromogranin A in plasma. GastroHep 1:1, pages 11-21.
Crossref
Vincenzo Marotta, Maria Chiara Zatelli, Concetta Sciammarella, Maria Rosaria Ambrosio, Marta Bondanelli, Annamaria Colao & Antongiulio Faggiano. (2018) Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocrine-Related Cancer 25:1, pages R11-R29.
Crossref
Mohamed Khalaf, Andrew S. Brock & Donald Castell. (2017) Sporadic Fundic Gland Polyps and Gastric Acid Suppression Level. The American Journal of the Medical Sciences 354:6, pages 561-564.
Crossref
Ryan K. Schmocker & Anne O. Lidor. (2017) Management of Non-neoplastic Gastric Lesions. Surgical Clinics of North America 97:2, pages 387-403.
Crossref
Kazuya Kato, Yoshiaki Iwasaki, Masahiko Taniguchi, Kazuhiko Onodera, Takako Kawakami, Minoru Matsuda, Mineko Higuchi, Kimitaka Kato, Yurina Kato, Susumu Tamakawa & Hiroyuki Furukawa. (2017) Successful treatment of proton pump inhibitor induced sporadic fundic gland polyps with an argon plasma coagulator in a patient with polycythaemia vera. International Journal of Surgery Case Reports 33, pages 75-78.
Crossref
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum & Reidar Fossmark. (2016) The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. European Journal of Gastroenterology & Hepatology 28:11, pages 1345-1352.
Crossref
Rudolf Repak, Darina Kohoutova, Miroslav Podhola, Stanislav Rejchrt, Marek Minarik, Lucie Benesova, Michal Lesko & Jan Bures. (2016) The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature. Gastrointestinal Endoscopy 84:4, pages 718-725.
Crossref
Sílvia Maria Perrone CAMILO, Élia Cláudia de Souza ALMEIDA, Benito André Silveira MIRANZI, Juliano Carvalho SILVA, Rosemary Simões NOMELINI & Renata Margarida ETCHEBEHERE. (2015) ENDOSCOPIC AND HISTOPATHOLOGIC GASTRIC CHANGES IN CHRONIC USERS OF PROTON-PUMP INHIBITORS. Arquivos de Gastroenterologia 52:1, pages 59-64.
Crossref
Stefan Karger, Tobias Wiesner, Anette Kersting, Miriam Braun, Thomas Ebert, Ulrike Wurst, Juergen Kratzsch, Michael Stumvoll & Mathias Fasshauer. (2014) Increased Chromogranin a and Carcinoid Syndrome-Like Symptons in a Patient Treated with Duloxetine. Endocrine Practice 20:11, pages 215-218.
Crossref
Can-ze Huang, Ren-xu Lai, Lei Mai, Huai-li Zhou, Hong-jiang Chen & Hui-xue Guo. (2014) Relative risk factors associated with the development of fundic gland polyps. European Journal of Gastroenterology & Hepatology 26:11, pages 1217-1221.
Crossref
Lise Pedersen & Mads Nybo. (2014) Preanalytical factors of importance for measurement of Chromogranin A. Clinica Chimica Acta 436, pages 41-44.
Crossref
PR Bech, NM Martin, R Ramachandran & SR Bloom. (2013) The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 51:1, pages 8-21.
Crossref
Yasser H. Shaib, Massimo Rugge, David Y. Graham & Robert M. Genta. (2013) Management of Gastric Polyps: An Endoscopy-Based Approach. Clinical Gastroenterology and Hepatology 11:11, pages 1374-1384.
Crossref
Fátima Carneiro & Gregory Y. Lauwers. 2013. Morson and Dawson's Gastrointestinal Pathology. Morson and Dawson's Gastrointestinal Pathology 180 222 .
Manfred Stolte. 2013. Pathologie. Pathologie 215 250 .
R. Fossmark, Ø. Sørdal, C. S. Jianu, G. Qvigstad, I. S. Nordrum, M. Boyce & H. L. Waldum. (2012) Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1067-1075.
Crossref
Adriana Zelter, José Luis Fernández, Claudio Bilder, Pablo Rodríguez, Andrés Wonaga, Fernanda Dorado, Miriam Galich & Luis Alberto Viola. (2010) Fundic Gland Polyps and Association with Proton Pump Inhibitor Intake: A Prospective Study in 1,780 Endoscopies. Digestive Diseases and Sciences 56:6, pages 1743-1748.
Crossref
Ben Lawrence, Bjorn I. Gustafsson, Mark Kidd, Marianne Pavel, Bernhard Svejda & Irvin M. Modlin. (2011) The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 40:1, pages 111-134.
Crossref
Rafael Molina, Elias Alvarez, Angeles Aniel-Quiroga, Maria Borque, Belen Candás, Antonio Leon, Rafael M. Poyatos & Montserrat Gelabert. (2010) Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies. Tumor Biology 32:1, pages 13-22.
Crossref
Usman Hammawa Malabu, Rozemary Karamatic, Gillian Mahy & Kunwarjit Singh Sangla. (2011) Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. Case Reports in Endocrinology 2011, pages 1-3.
Crossref
Giovanni Gori, Giacomo Spinelli, Claudio Spinelli, Marco Tuccori, Corrado Blandizzi & Mario Del Tacca. (2010) Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia. Nature Reviews Gastroenterology & Hepatology 7:11, pages 642-646.
Crossref
Constantin S. Jianu, Reidar Fossmark, Unni Syversen, Øyvind Hauso & Helge L. Waldum. (2010) A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia. Tumor Biology 31:5, pages 373-380.
Crossref
Irvin M. Modlin, Bjorn I. Gustafsson, Steven F. Moss, Marianne Pavel, Apostolos V. Tsolakis & Mark Kidd. (2010) Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease. Annals of Surgical Oncology 17:9, pages 2427-2443.
Crossref
Mazer R. Ally, Ganesh R. Veerappan, Corinne L. Maydonovitch, Timothy J. Duncan, Joseph L. Perry, Eric M. Osgard & Roy K. H. Wong. (2009) Chronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland Polyps. Digestive Diseases and Sciences 54:12, pages 2617-2622.
Crossref
J. W. FRESTON, M. HISADA, D. A. PEURA, M. M. HABER, T. O. KOVACS, S. ATKINSON & B. HUNT. (2009) The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis. Alimentary Pharmacology & Therapeutics 29:12, pages 1249-1260.
Crossref
P. JUUL‐HANSEN & A. RYDNING. (2008) On‐demand requirements of patients with endoscopy‐negative gastro‐oesophageal reflux disease: H2‐blocker vs. proton pump inhibitor. Alimentary Pharmacology & Therapeutics 29:2, pages 207-212.
Crossref
Mitchell L Schubert. (2008) Gastric secretion. Current Opinion in Gastroenterology 24:6, pages 659-664.
Crossref
Hugh James Freeman. (2008) Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World Journal of Gastroenterology 14:9, pages 1318.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.